• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在哺乳动物细胞内表达的Y13-259单链抗体片段的作用模式。

The mode of action of Y13-259 scFv fragment intracellularly expressed in mammalian cells.

作者信息

Cardinale A, Lener M, Messina S, Cattaneo A, Biocca S

机构信息

Department of Neuroscience, University of Rome Tor Vergata, Roma, Italy.

出版信息

FEBS Lett. 1998 Nov 20;439(3):197-202. doi: 10.1016/s0014-5793(98)01369-6.

DOI:10.1016/s0014-5793(98)01369-6
PMID:9845322
Abstract

The anti-p21ras Y13-259 single-chain Fv fragment (scFv) neutralizes the activity of p21-ras when intracellularly expressed in different systems. We have studied the mode of action of this inhibition in 3T3 K-ras fibroblasts and demonstrated that (i) this antibody fragment is highly aggregating when cytoplasmically expressed and (ii) the p21-ras antigen is sequestered in these aggregates in an antibody-dependent manner. This co-segregation leads to an efficient inhibition of DNA synthesis. These results suggest that an antigen can be diverted from its normal location inside the cells in an antibody mediated way, prospecting a new mode of action for intracellular antibodies in vivo.

摘要

抗p21ras Y13 - 259单链Fv片段(scFv)在不同系统中细胞内表达时可中和p21 - ras的活性。我们研究了这种抑制作用在3T3 K - ras成纤维细胞中的作用方式,并证明:(i)该抗体片段在细胞质中表达时高度聚集;(ii)p21 - ras抗原以抗体依赖的方式被隔离在这些聚集体中。这种共分离导致DNA合成的有效抑制。这些结果表明,抗原可以通过抗体介导而从细胞内的正常位置被转移,为体内细胞内抗体的作用方式开辟了新途径。

相似文献

1
The mode of action of Y13-259 scFv fragment intracellularly expressed in mammalian cells.在哺乳动物细胞内表达的Y13-259单链抗体片段的作用模式。
FEBS Lett. 1998 Nov 20;439(3):197-202. doi: 10.1016/s0014-5793(98)01369-6.
2
Diverting a protein from its cellular location by intracellular antibodies. The case of p21Ras.通过细胞内抗体改变蛋白质的细胞定位。以p21Ras为例。
Eur J Biochem. 2000 Feb;267(4):1196-205. doi: 10.1046/j.1432-1327.2000.01125.x.
3
Intracellular expression and functional properties of an anti-p21Ras scFv derived from a rat hybridoma containing specific lambda and irrelevant kappa light chains.源自含有特异性λ链和无关κ链的大鼠杂交瘤的抗p21Ras单链抗体片段的细胞内表达及功能特性
Mol Immunol. 1998 Dec;35(17):1097-110. doi: 10.1016/s0161-5890(98)00105-9.
4
Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression.一种中和p21 ras的抗体片段的细胞内表达促进肿瘤消退。
Cancer Res. 1998 Mar 15;58(6):1170-6.
5
Aggresome formation by anti-Ras intracellular scFv fragments. The fate of the antigen-antibody complex.抗Ras细胞内单链抗体片段形成聚集体。抗原-抗体复合物的命运。
Eur J Biochem. 2001 Jan;268(2):268-77. doi: 10.1046/j.1432-1033.2001.01876.x.
6
Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: a novel approach for cancer therapy?用重组单链Fv(scFv)片段进行Ras和p53细胞内靶向:癌症治疗的新方法?
Cancer Detect Prev. 1999;23(6):506-10. doi: 10.1046/j.1525-1500.1999.99058.x.
7
Use of living columns to select specific phage antibodies.使用活柱筛选特定噬菌体抗体。
Biotechnology (N Y). 1993 Dec;11(13):1565-9. doi: 10.1038/nbt1293-1565.
8
A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues.一种新型抗p21Ras单链抗体,可特异性与人肿瘤细胞系和原发性肿瘤组织发生反应。
BMC Cancer. 2016 Feb 20;16:131. doi: 10.1186/s12885-016-2168-6.
9
Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria.靶向内质网、细胞质和线粒体的单链Fv片段的氧化还原状态。
Biotechnology (N Y). 1995 Oct;13(10):1110-5. doi: 10.1038/nbt1095-1110.
10
Intracellular expression of anti-p21ras single chain Fv fragments inhibits meiotic maturation of xenopus oocytes.
Biochem Biophys Res Commun. 1993 Dec 15;197(2):422-7. doi: 10.1006/bbrc.1993.2496.

引用本文的文献

1
Targeting the "undruggable" RAS with biologics.利用生物制剂靶向“不可成药的”RAS
Adv Cancer Res. 2022;153:237-266. doi: 10.1016/bs.acr.2021.07.006. Epub 2021 Aug 13.
2
Biology, pathology, and therapeutic targeting of RAS.RAS 的生物学、病理学和治疗靶点。
Adv Cancer Res. 2020;148:69-146. doi: 10.1016/bs.acr.2020.05.002. Epub 2020 Jul 9.
3
Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology.细胞内抗体应用:神经生物学、病毒学和肿瘤学的原理和最新进展。
BioDrugs. 2020 Aug;34(4):435-462. doi: 10.1007/s40259-020-00419-w.
4
An ultra-stable cytoplasmic antibody engineered for in vivo applications.一种用于体内应用的超稳定细胞质抗体。
Nat Commun. 2020 Jan 17;11(1):336. doi: 10.1038/s41467-019-13654-9.
5
Therapeutic targeting of RAS: New hope for drugging the "undruggable".靶向治疗 RAS:为“不可成药”带来新希望。
Biochim Biophys Acta Mol Cell Res. 2020 Feb;1867(2):118570. doi: 10.1016/j.bbamcr.2019.118570. Epub 2019 Oct 31.
6
Direct inhibition of RAS: Quest for the Holy Grail?直接抑制 RAS:圣杯的追寻?
Semin Cancer Biol. 2019 Feb;54:138-148. doi: 10.1016/j.semcancer.2017.12.005. Epub 2017 Dec 14.
7
Synaptic plasticity through activation of GluA3-containing AMPA-receptors.通过激活含 GluA3 的 AMPA 受体实现突触可塑性。
Elife. 2017 Aug 1;6:e25462. doi: 10.7554/eLife.25462.
8
Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm.哺乳动物细胞质中可溶内体表达的理化决定因素。
Protein Eng Des Sel. 2010 Jun;23(6):489-98. doi: 10.1093/protein/gzq022. Epub 2010 Apr 8.
9
Novel antibody derivatives for proteome and high-content analysis.用于蛋白质组和高内涵分析的新型抗体衍生物。
Anal Bioanal Chem. 2010 Aug;397(8):3203-8. doi: 10.1007/s00216-010-3657-0. Epub 2010 Apr 7.
10
The intrabody targeting of hTERT attenuates the immortality of cancer cells.hTERT 内体靶向降低了癌细胞的永生性。
Cell Mol Biol Lett. 2010;15(1):32-45. doi: 10.2478/s11658-009-0032-2. Epub 2009 Sep 23.